Myoglobin for Detection of High-Risk Patients with Acute Myocarditis
暂无分享,去创建一个
J. Lima | R. Manka | T. Lüscher | U. Landmesser | C. Schmied | C. Templin | D. Fairweather | B. Heidecker | J. Berg | K. A. Bruno | Gary R. Salomon | C. Kissel | J. Kottwitz | N. Baltensperger | M. Lovrinovic | Mawahib Elhassan | Andrea Baltensweiler | Bettina Heidecker
[1] Tobias Reichlin,et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. , 2019, Clinical chemistry.
[2] L. Cooper,et al. Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis , 2019, Journal of the American Heart Association.
[3] N. Hagiwara,et al. An autopsy case of giant cell myocarditis showing shared pathology in the myocardium and skeletal muscles. , 2019, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[4] T. Kiernan,et al. A Young Male with Severe Myocarditis and Skeletal Muscle Myositis , 2018, Case reports in cardiology.
[5] K. Selthofer-Relatić. Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation , 2018, Case reports in cardiology.
[6] Dorin Comaniciu,et al. Early diagnosis of acute coronary syndrome , 2017, European heart journal.
[7] R. Manka,et al. Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up , 2017, Circulation. Heart failure.
[8] G. Pontone,et al. Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.
[9] R. Blankstein,et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. , 2017, Journal of the American College of Cardiology.
[10] P. Damman,et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group , 2016, Netherlands Heart Journal.
[11] C. Yancy,et al. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.
[12] L. Cooper,et al. Imaging of Inflammation in Unexplained Cardiomyopathy. , 2016, JACC. Cardiovascular imaging.
[13] Matthias Gutberlet,et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.
[14] P. Croisille,et al. Myocardial biomarkers and delayed enhanced cardiac magnetic resonance relationship in clinically suspected myocarditis and insight on clinical outcome , 2015, Journal of cardiovascular medicine.
[15] G. Vanzetto,et al. Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis outcome , 2014, Journal of magnetic resonance imaging : JMRI.
[16] W. Hua,et al. The prognostic use of serum concentrations of cardiac troponin-I, CK-MB and myoglobin in patients with idiopathic dilated cardiomyopathy. , 2014, Heart & lung : the journal of critical care.
[17] T. Guilarte,et al. Sex Differences in Translocator Protein 18 kDa (TSPO) in the Heart: Implications for Imaging Myocardial Inflammation , 2014, Journal of Cardiovascular Translational Research.
[18] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[19] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[20] S. Huber,et al. Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy , 2013, Current protocols in immunology.
[21] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[22] K. Klingel,et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.
[23] S. Aggarwal,et al. Myopericarditis in Children: Elevated Troponin I Level Does Not Predict Outcome , 2012, Pediatric Cardiology.
[24] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .
[25] L. Cooper,et al. The management of myocarditis. , 2011, European heart journal.
[26] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[27] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.
[28] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[29] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .
[30] A. Angelini,et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.
[31] S. Heymans. Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. , 2007, European heart journal.
[32] K. Klingel,et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.
[33] J. Schulz-Menger,et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.
[34] H. Rickli,et al. Long-term outcome of acute myocarditis is independent of cardiac enzyme release. , 2003, International journal of cardiology.
[35] N. Rose,et al. From infection to autoimmunity. , 2001, Journal of autoimmunity.
[36] P. Clopton,et al. A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran's Hospital , 2000, Clinical cardiology.
[37] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[38] U. Flögel,et al. Disruption of myoglobin in mice induces multiple compensatory mechanisms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Kost,et al. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction. , 1998, Archives of pathology & laboratory medicine.
[40] B. Strauer,et al. Cardiac troponin T in patients with clinically suspected myocarditis. , 1997, Journal of the American College of Cardiology.
[41] A. Jaffe,et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. , 1997, Circulation.
[42] J. Maessen,et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. , 1995, Circulation.
[43] J. Mair,et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin , 1992, British heart journal.
[44] A. Matsumori,et al. Relation between myoglobin and cardiac dysfunction in myocarditis--immunohistochemical study of endomyocardial biopsy specimens. , 1991, Japanese circulation journal.
[45] A. Ellis,et al. Kinetics of myoglobin release and prediction of myocardial myoglobin depletion after coronary artery reperfusion. , 1989, Circulation.
[46] R. Virmani,et al. Sudden cardiac death in Air Force recruits. A 20-year review. , 1986, JAMA.
[47] R. Roberts,et al. Myoglobin in myocardial infarction. , 1978, Annals of internal medicine.
[48] L. Kagen. Myoglobin: methods and diagnostic uses. , 1978, CRC critical reviews in clinical laboratory sciences.